MYO5B and schizophrenia: In addition, dysfunction of glutamatergic signaling in the brain may be involved in the pathophysiology of schizophrenia, and myosin Vb (MYO5B) contributes to glutamate receptor 1(GluR1) signaling, suggesting a link between glutamatergic signaling and schizophrenia [24].